Trial intelligence / Profile preview

ACCESS: Fe-ASP vs Ferrous Sulfate in Iron Deficiency Anemia

NCT03524651Phase 4Completed

Sponsor
Uni-Pharma
Start
May 2018
Primary completion
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of iron protein acetylaspartate in iron deficiency anemia (IDA), sponsored by Uni-Pharma. Started May 2018; status: completed.

02

Drugs

iron protein acetylaspartate
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT03524651.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03524651.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call